Coya Therapeutics Inc
COYA
NASDAQ
Biotechnology
$4.79
USD
+0.12 (+2.57%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $109.55M
Volume 113.6K
About Coya Therapeutics Inc
The company is headquartered in Houston, Texas and currently employs 8 full-time employees. The company went IPO on 2022-12-29.
CEO
Dr. Arun Swaminathan
HQ
Houston, TEXAS, US
Founded
2022
Employees
8
Quantli Score
8.4
Outperform
Fin. Health
8.1
Profitability
7.6
Growth
9.0
Cash-Flow Q.
8.8
Key Metrics
6 metrics our research team weighs before forming a view on COYA.
Based on Quantli research · SEC filings · as of Q2 2026
METRIC
VALUE
CHANGE
TREND (3Y)
Revenue Growth (TTM)
1793.8%
+1889.3 pp
Gross Margin (TTM)
100.0%
0.0 pp
Operating Margin (TTM)
-288.7%
+5053.6 pp
Net Margin (TTM)
-270.2%
+4532.9 pp
ROE (TTM)
-50.1%
+21.8 pp
Free Cash Flow (TTM)
$-15.72M
—
Financial Snapshot
Revenue
$8.02M
+1793.8%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-21.67M
-6.5%
YoY
Operating Cash Flow
$-15.72M
+4.6%
YoY
Key Statistics
Open
$4.70
Previous Close
$4.67
Day Range
$4.55 - $4.85
52 Week Range
$3.71 - $7.75
Volume
113.6K
Average Volume (10 Days)
150.0K
Dividend Yield
—
Valuation Measurement
Market Cap
$109.55M
P/E Ratio (TTM)
—
P/S Ratio (TTM)
13.66
Price / Book
2.53
Financial Highlights
Profit Margin
-270.2%
Return on Assets
-45.8%
Return on Equity
-50.1%
Revenue (TTM)
$8.02M
Net Income (TTM)
$-21.67M
Diluted EPS (TTM)
-$1.07
Total Cash (MRQ)
$43.18M
Levered FCF (TTM)
$-15.72M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Similar Stocks
Earnings Calendar
Next Earnings
Estimated Q2 Release
Aug 18
Est. EPS
Adjusted consensus estimate
-$0.35
Analyst Consensus
Based on 2 analyst ratings
Avg Target: $13.00
(+171.4% upside)
High: $14.00 · Low: $12.00
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%